Cardiology in Review

AUG 3, 2026 · JOURNAL ARTICLE

SGLT2 Inhibitors in the Modern Cardiology Era: Mechanisms, Outcomes, and Clinical Applications

Cardiology in Review

A narrative review synthesizing mechanisms and trial evidence for SGLT2 inhibitors across heart failure and CKD, positioning them as foundational therapies; evidence quality varies by outcome and lacks quantified effect sizes.

JUL 6, 2026 · JOURNAL ARTICLE

Beta-Blockers Versus Flecainide for Atrial Fibrillation: A First-Line Strategy Review of Efficacy, Safety, and Patient Selection

Cardiology in Review

A state-of-the-art clinical review synthesizing landmark trials and recent guidelines to provide evidence-based recommendations for first-line AF drug selection, without new primary data.